Cart summary

You have no items in your shopping cart.

Asperulosidic acid

SKU: orb1218276

Description

Asperulosidic acid has anti-tumor, anti-oxidant, and anti-inflammatory activities.ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways.

Images & Validation

Key Properties

CAS Number25368-11-0
MW432.4
Purity>98% (HPLC)
FormulaC18H24O12
SMILESOC[C@H]([C@@H](O)[C@H](O)[C@H]1O)O[C@@]1([H])O[C@H]2[C@@]3([H])[C@@]([C@@H](O)C=C3COC(C)=O)([H])C(C(O)=O)=CO2
TargetERK
SolubilityIn Vitro: DMSO : 100 mg/mL (231.28 mM)

Bioactivity

In Vitro
Asperulosidic Acid (ASPA) (40-160 μg/mL; pre- 1 hour) significantly down-regulates the mRNA levels of TNF-α and IL-6 in LPS-induced RAW 264.7 cells compared with the group treated with LPS alone. Asperulosidic Acid (ASPA) (40-160 μg/mL; pre- 1 hour) decreases IκB-α phosphorylation in a concentration-dependent manner, decreases Erk1/2 phosphorylation at all concentration levels, but there was no effect on p-p38. RT-PCR Cell line: RAW 264.7 cells Concentration: 40 μg/mL, 80 μg/mL, and 160 μg/mL. Incubation time: Pre-treatment 1 hour. Result: Decreased TNF-α and IL-6 mRNA expression. Western blot analysis. Cell line: RAW 264.7 cells Concentration: 40 μg/mL, 80 μg/mL, and 160 μg/mL. Incubation time: Pre-treatment 1 hour. Result: Decreased IκB-α phosphorylationand Erk1/2 phosphorylation.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ASPA

Similar Products

  • Asperulosidic acid (Standard) [orb3139582]

    25368-11-0

    432.38

    C18H24O12

    10 mg
  • Deacetylasperulosidic Acid [orb1299069]

    99.88% (May vary between batches)

    14259-55-3

    390.34

    C16H22O11

    5 mg, 10 mg, 25 mg, 1 mg, 50 mg, 100 mg
  • Methyl deacetylasperulosidate [orb1301540]

    99.30%

    52613-28-2

    404.37

    C17H24O11

    10 mg, 50 mg, 100 mg, 5 mg, 25 mg, 2 mg, 1 ml x 10 mM (in DMSO)
  • Methyl asperulosidic acid [orb2893227]

    949488-79-3

    446.40

    C19H26O12

    50 mg, 10 mg
  • Asperulosidic acid [orb1297459]

    99.47% (May vary between batches)

    25368-11-0

    432.38

    C18H24O12

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO), 100 mg, 2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Asperulosidic acid (orb1218276)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
5 mg
$ 460.00
10 mg
$ 760.00
25 mg
$ 1,180.00
50 mg
$ 1,540.00